Today, 20 May, marks Clinical Trials Day. This year’s theme, set by the Association of Clinical Research Professionals (ACRP), is “Research Rising”, highlighting the heart, strength, and resilience of clinical research professionals who turn determination into medical progress.
Ahead of Clinical Trials Day, Clinical Trials Arena editor Abigail Beaney spoke with Mel Mann, a chronic myeloid leukaemia (CML) patient who was one of the first people globally to be enrolled on the Phase I clinical trial of Gleevac (imatinib) in 1988.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Mann shares his experience from his diagnosis to now, 40 years later, and how he attributes the clinical trial to saving his life. Mann also calls for more awareness of research and for sponsors to better support patients between trials ending and drug approval.
You can listen to the podcast below:
This podcast was recorded at Arena International’s Outsourcing in Clinical Trials East Coast event, held on 12 and 13 May 2026.
A detailed agenda for 17th Annual Outsourcing in Clinical Trials East Coast 2026 conference can be accessed here. The conference is hosted by Arena International Events Group, a B2B events company owned by GlobalData, the parent company of Clinical Trials Arena and Pharmaceutical Technology.
Interested in attending or sponsoring OCT East Coast? Complete the form below and the Arena team will be in touch.
